Two Sigma Advisers’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-83,443
Closed -$347K 631
2025
Q4
$347K Buy
83,443
+31,419
+60% +$178K ﹤0.01% 1933
2025
Q3
$287K Buy
+52,024
New +$249K ﹤0.01% 2006
2024
Q1
Sell
-16,670
Closed -$183K 2494
2023
Q4
$183K Buy
+16,670
New +$180K ﹤0.01% 2248
2022
Q4
Sell
-463
Closed -$18K 2558
2022
Q3
$18K Sell
463
-890
-66% -$42.3K ﹤0.01% 2447
2022
Q2
$65K Sell
1,353
-1,324
-49% -$77.7K ﹤0.01% 2448
2022
Q1
$247K Buy
2,677
+1,570
+142% +$213K ﹤0.01% 2311
2021
Q4
$246K Sell
1,107
-1,940
-64% -$542K ﹤0.01% 2213
2021
Q3
$1.05M Buy
3,047
+1,560
+105% +$529K ﹤0.01% 1594
2021
Q2
$558K Buy
+1,487
New +$447K ﹤0.01% 1903
2021
Q1
Sell
-1,353
Closed -$339K 2603
2020
Q4
$339K Sell
1,353
-6,554
-83% -$1.61M ﹤0.01% 2008
2020
Q3
$1.46M Buy
7,907
+5,037
+176% +$1M ﹤0.01% 1322
2020
Q2
$717K Buy
2,870
+1,900
+196% +$416K ﹤0.01% 1734
2020
Q1
$175K Buy
+970
New +$254K ﹤0.01% 2202

Other funds holding DTIL

Two Sigma Advisers's DTIL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 83,443 shares — an estimated $347K sold.

Two Sigma Advisers first reported a position in DTIL in Q1 2020 and held it in 13 quarters. The position peaked at $1.46M in Q3 2020. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Two Sigma Advisers reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 83,443 Precision BioSciences shares in Q1 2026, an estimated $347K.
  • Two Sigma Advisers first reported a position in Precision BioSciences in Q1 2020 and held it in 13 quarters.
  • Two Sigma Advisers's Precision BioSciences position peaked at $1.46M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.